Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Repligen Corporation, 3 years.
Repligen Corporation
Director
Neuronetics Inc.
Director
Cytek Biosciences Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Cytek Biosciences Inc. | Option exercise | +3,086 | โ | โ |
| May 28, 2026 | Neuronetics Inc. | Grant or award | +30,000 | โ | โ |
| May 14, 2026 | Repligen Corporation | Grant or award | +995 | โ | โ |
| May 7, 2026 | Repligen Corporation | Option exercise | +2,434 | $38.76 | $94,342 |
| Dec 16, 2025 | Repligen Corporation | Option exercise | +3,366 | $26.12 | $87,920 |
| Oct 20, 2025 | Neuronetics Inc. | Grant or award | +7,554 | โ | โ |
| May 22, 2025 | Neuronetics Inc. | Grant or award | +30,000 | โ | โ |
| May 15, 2025 | Repligen Corporation | Grant or award | +973 | โ | โ |
| Feb 7, 2025 | Neuronetics Inc. | Other | +44,444 | $2.25 | $99,999 |
| Nov 19, 2024 | Repligen Corporation | Option exercise | +19,000 | $36.29 | $689,510 |
| Sep 5, 2024 | Neuronetics Inc. | Open-market purchase | +25,000 | $0.80 | $20,000 |
| Aug 29, 2024 | Neuronetics Inc. | Open-market purchase | +12,224 | $0.85 | $10,390 |
| Aug 28, 2024 | Neuronetics Inc. | Open-market purchase | +12,776 | $0.85 | $10,860 |
| Aug 20, 2024 | Neuronetics Inc. | Open-market purchase | +25,000 | $1.00 | $25,000 |
| Aug 14, 2024 | Neuronetics Inc. | Open-market purchase | +25,171 | $0.75 | $18,878 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.